CDK9 and prostate carcinoma: No specific biological values were disclosed, but the most potent inhibitors claimed to have >70% inhibition at 500 nM in in vitro CDK9 assay and >70% inhibition at 10 μM in a proliferation assay against five cell lines, including the prostate cancer cell lines PC-3.81